Aromatase inhibitor

Breast cancer drugs may force some cancer cells into sleeper mode, allowing them to potentially come back to life years...


The purpose of a study was to evaluate the development in the use of medications associated with an increased risk...


The FDA ( U.S. Food and Drug Administration ) has extended the indication of Ibrance ( Palbociclib ) capsules in...


The FDA ( U.S. Food and Drug Administration ) has approved Piqray ( Alpelisib ) tablets, to be used in...


Results of the global phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor Alpelisib ( BYL719 ) has met...


Role of aromatase inhibitors and Zoledronic acid ( Zometa ) as adjuvant treatment of premenopausal endocrine-responsive breast cancer patients is...


The FDA ( US Food and Drug Administration ) has approved Kisqali ( Ribociclib ) for women with hormone-receptor positive,...



Aromatase inhibitors effectively prevent breast cancer recurrence and development of new contralateral tumours in postmenopausal women. Researchers have assessed the...


The International Breast Cancer Study Group ( IBCSG ) has presented results of the randomized phase III SOFT trial at...


As predicted by their DNA-damaging mechanism of action, Platinum compounds are expected to be particularly active in tumours deficient of...


Patients with breast cancer are classified as having cells that over-express the human epidermal growth factor receptor 2 ( known...


The International Breast Cancer Study Group ( IBCSG ) has presented results of the randomized phase III SOFT clinical trial...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion recommending a variation to...


The American Society of Clinical Oncology ( ASCO ) issued a newly updated clinical practice guideline on pharmacological prevention interventions...


A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study...


A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for...


Amgen has informed physicians of important safety information for Prolia ( Denosumab ) and updates to the Prescribing Information.Prolia was...


Treatment with the aromatase inhibitor Letrozole ( Femara ) can reduce the risk of breast cancer recurrence even when initiated...


Treatment with the aromatase inhibitor Letrozole ( Femara ) can reduce the risk of breast cancer recurrence even when initiated...